Abstract:Ethnopharmacological relevance: The seeds of Peganum harmala Linn, in which the most abundant active compounds are harmaline and harmine, have been widely used as a traditional medicine in various countries to treat a broad spectrum of diseases including asthma, cough, depression, Parkinson's and Alzheimer's diseases. However, few studies on long-term or subchronic toxicity of seeds of P. harmala were reported after overdose. Aim of the study: To investigate the subchronic toxicity and concomitant toxicokinetics of total alkaloid extracts from seeds of P. harmala (TAEP) after oral administration for four weeks in rats. Materials and methods: The subchronic toxicity and concomitant toxicokinetics of TAEP were evaluated after 28-day oral administration in rats at daily dose levels of 15, 45, and 150 mg/kg. The signs of toxicity and mortality were monitored and recorded daily. The body weight and average food consumption were measured weekly. The analyses of hematology, biochemistry, urine, relative organ weights and histopathology were conducted at the termination of treatment and recovery phase. For concomitant toxicokinetics study, the plasma toxicokinetic parameters, tissue distribution, and excretion of predominant ingredients harmaline and harmine in TAEP and metabolites harmalol and harmol were tested. Results: Following initial repeated exposure to high-dose (150 mg/kg/day) of TAEP excitotoxic reaction, such as tremor, was observed, but tolerated on the fourth day after multiple dosing. The significant alterations in blood glucose and lipid metabolism in liver were observed, but recovered after four weeks of drug withdrawal. The no-observed-adverse-effect level (NOAEL) of TAEP was considered to be 45 mg/kg/day under the present study conditions. There were no significant gender differences in most indexes of subchronic toxicity throughout the experimental period with the exception of food consumption and body weight. In concomitant toxicokinetics study, the alterations of dynamic characteristic for harmaline, harmine and metabolite harmol after multiple oral administration at three doses had been observed. Harmaline, harmine and metabolites harmalol and harmol were widely distributed in organs and there was no accumulation in the tissues examined. The reduction of harmaline and metabolite harmalol in brain after multiple dosing at dose of 150 mg/kg might be closely related to the tremor tolerance. The main excretory pathway for metabolites harmalol and harmol was urinary excretion via kidney. Conclusions: The results revealed that TAEP at doses of 15 and 45 mg/kg/day in rats might be safe. Excitotoxic reaction such as tremor occurred initially at dose of 150 mg/kg/day, however, the toxicity was tolerant and reversible. In addition, harmaline and harmine in TAEP had a quick absorption into blood and metabolized to harmalol and harmol, and there was no drug accumulation in the detected tissues. Further studies should be investigated to clarify the mechanisms of tremor tolerance and neurotoxicity of TAEP.

A 180-Day Subchronic Oral Toxicity Study of Total Flavones of <i>E. leptorrhizum</i> Stearn in Rats

Study on Subchronic Toxicity of Fluazifop-p-butyl to SD Rats

Sub-chronic Toxicity Test of Ginseng Leaf Oral Liquid in Rats

Evaluation of toxicity studies of flavonoid fraction of Lithocarpus polystachyus Rehd in rodents

The Oral Noael Of Flurochloridone In Male Wistar Rats In Ninety-Day Subchronic Toxicity Test Was 3mg/Kg/Day

A 90-Day Oral Toxicity Study of the Ethanol Extract from Eupatorium Japonicum Thunb and Foeniculum Vulgare in Rats

A 15-Day Oral Dose Toxicity Study of Aspirin Eugenol Ester in Wistar Rats.

Thirty-day SD Rat Feeding Test of Acylated Tea Polyphenols

Acute and subchronic oral toxicity of fluoranthene in F-344 rats

Study on Chronic Toxicity of Water Extraction Components from Evodia Fructus in Rats

Ninety Day Toxicity And Toxicokinetics Of Fluorochloridone After Oral Administration In Rats

Subchronic toxicity and concomitant toxicokinetics of long-term oral administration of total alkaloid extracts from seeds of Peganum harmala Linn: A 28-day study in rats

Evaluation of Arecoline Hydrobromide Toxicity after a 14-Day Repeated Oral Administration in Wistar Rats.

Acute and 13weeks Subchronic Toxicological Evaluation of Naringin in Sprague-Dawley Rats

A subchronic toxicity study of ethanol root extract of baked Aconitum flavum in rats

Study on toxicological experiments of the extract from fermentative products of Tremella aurantialba

90-Day Subchronic Toxicity Study of Aloe Whole-Leaf Powder

Subchronic Toxicity Studies of Radix Astragali Extract in Rats and Dogs

An Observation on Long-term Toxicity of Hongyexintong Soft Capsules to Rats

Study on Chronic Toxicity of Volatile Oil from Evodia Fructus in Rats

Ninety-Day Subchronic Oral Toxicity Study of Senecio Scandens Extract in Rats.

A 180-Day Subchronic Oral Toxicity Study of Total Flavones of &lt;i&gt;E. leptorrhizum&lt;/i&gt; Stearn in Rats